- Home
- YSXT vs MRSN Comparison
YSXT vs MRSN Comparison
Compare YSXT & MRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YSXT
- MRSN
- Stock Information
- Founded
- YSXT 2011
- MRSN 2001
- Country
- YSXT China
- MRSN United States
- Employees
- YSXT N/A
- MRSN N/A
- Industry
- YSXT Automotive Aftermarket
- MRSN Biotechnology: Pharmaceutical Preparations
- Sector
- YSXT Consumer Discretionary
- MRSN Health Care
- Exchange
- YSXT Nasdaq
- MRSN Nasdaq
- Market Cap
- YSXT 87.9M
- MRSN 71.9M
- IPO Year
- YSXT 2024
- MRSN 2017
- Fundamental
- Price
- YSXT $2.85
- MRSN $0.34
- Analyst Decision
- YSXT
- MRSN Buy
- Analyst Count
- YSXT 0
- MRSN 3
- Target Price
- YSXT N/A
- MRSN $4.00
- AVG Volume (30 Days)
- YSXT 7.5K
- MRSN 3.0M
- Earning Date
- YSXT 02-24-2025
- MRSN 03-03-2025
- Dividend Yield
- YSXT N/A
- MRSN N/A
- EPS Growth
- YSXT N/A
- MRSN N/A
- EPS
- YSXT 0.18
- MRSN N/A
- Revenue
- YSXT $66,143,276.00
- MRSN $40,497,000.00
- Revenue This Year
- YSXT N/A
- MRSN N/A
- Revenue Next Year
- YSXT N/A
- MRSN N/A
- P/E Ratio
- YSXT $14.77
- MRSN N/A
- Revenue Growth
- YSXT 21.23
- MRSN 9.88
- 52 Week Low
- YSXT $2.06
- MRSN $0.32
- 52 Week High
- YSXT $6.27
- MRSN $4.64
- Technical
- Relative Strength Index (RSI)
- YSXT N/A
- MRSN 29.53
- Support Level
- YSXT N/A
- MRSN $0.41
- Resistance Level
- YSXT N/A
- MRSN $0.42
- Average True Range (ATR)
- YSXT 0.00
- MRSN 0.04
- MACD
- YSXT 0.00
- MRSN -0.00
- Stochastic Oscillator
- YSXT 0.00
- MRSN 11.85
About YSXT YSX Tech. Co. Ltd Class A Ordinary Shares
YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services and Software Development and Information Technology Services. Key revenue is generated from Auto Insurance Aftermarket Value-added Services segment which include four types value added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services and vehicle maintenance and other value-added services.
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company using its differentiated and proprietary ADC platforms to develop targeted drugs with increased tolerability and expanded opportunities to deliver meaningful clinical benefits to patients. The Company's early stage programs includes XMT-1660, a Dolasynthen ADC targeting B7-H4, as well as XMT-2056, a STING agonist ADC developed using the Company's Immunosynthen platform and targeting a novel epitope of human epidermal growth factor receptor 2. The Company also has two earlier stage preclinical candidates, XMT-2068 and XMT-2175, both of which leverage the Company's Immunosynthen platform and target tumor-associated antigens.